Searched for
DIFFERENTIAL TREATMENT DRIVERS
PE wars to billion-dollar IPO dreams, hospital sector is fighting fitMajor private equity firms are vying for a stake in Cloudnine, a leading maternity and paediatric care chain. This intense competition high...- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- I-Beauty! After J, K and C, now it's India's turn in the big beautiful marketIndia's beauty industry is emerging as a global force, blending Ayurvedic heritage with modern science to create "I-beauty." With rising ex...
- Portugal eyes bigger role in India’s infrastructure, manufacturing push as trade ties deepenPortugal's Minister of State for Economy, João Rui Ferreira, expressed readiness to contribute to India's infrastructure goals, highlightin...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- GIFT City vs Dubai vs Singapore: What you need to know while choosing your investment hubIndian wealth is increasingly seeking global anchors, with GIFT City, Dubai's DIFC and Singapore emerging as key contenders. Each hub offer...
- It's not just war that brought rupee down, it needs better supportThe West Asia conflict has accelerated INR depreciation, necessitating a rethink of India's economic fundamentals. Short-term measures incl...
- Capital with purpose: How capital markets are shaping the future of medicine with Dheeraj ChinthalapellyDheeraj Chinthalapelly, with a decade and a half of experience in global capital markets, shares his journey navigating the biotech investm...
- Medical tourism 2.0: Why dental tourism could be India’s next big healthcare exportIndia's dental tourism is experiencing significant growth. International patients are increasingly choosing India for advanced dental care,...
- Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
- Price alone won't push weight-loss, diabetes drug semaglutide sales: DoctorsLeading drugmakers including Sun Pharmaceuticals, Dr Reddy’s Laboratories, Zydus Lifesciences, Natco Pharma, Eris Lifesciences, USV, Glenma...
- Uber faces protest in Bengaluru over earnings and driver policy concernsCab drivers protested outside Uber's Bengaluru center on Monday. They alleged reduced earnings due to differential treatment between fleet ...
- Delhi HC upholds GST on auto ride through platforms like UberUber India had contended the notifications were violative of Article 14 (equality before law) of the Constitution of India as they failed t...
- Delhi HC upholds govt notifications imposing GST on Ola, Uber autos ridesWhile dismissing Uber’s petition challenging the levy of GST, the HC held that the notifications under challenge did not result in discrimi...
- Fundamental Radar: This multibagger stock looks set to hit fresh 52-week highs in 2023; here’s whyKaustubh Pawaskar, DVP Fundamental Research at Sharekhan by BNP Paribas highlights 5 factors why Healthcare Global Enterprises is a top buy...
- Dentalcare startup Smiles raises $23 million from Alpha Wave, Sequoia IndiaSmiles.ai said it will deploy this funding towards expanding its footprint nationally, strengthening the leadership team, and building tech...
- Glenmark's subsidiary Ichnos Sciences enters pact with Almirall for novel drug to treat autoimmune diseasesUnder the agreement, Almirall is granted global rights to develop and commercialize this monoclonal antibody for autoimmune diseases. Ichno...
- Is e-buying suitable for every insurance policy? Find outBefore you shop online, you need to understand the features of insurance policy correctly and get the quantum of your cover right.
- Brokerages raise price target on Dr Reddy's to as high as Rs 2,720 on FDA nodBrokerages see the FDA approval to Dr Reddy’s Laboratories (DRL) for generic Vidaza as a positive for the company.
- Spinning money out of waste at Richcore LifesciencesThe firm is in talks with companies in Chile, Japan, Middle East, Brazil and many European nations for providing its waste water treatment ...
Load More
